Yissum - Research Development Company of the Hebrew University

Sp1-Protein Variants as Novel Scaffolds for the Formation of Functional Interfaces Between Electrodes, Neurons, Cells and their Surroundings

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Innovative Products and Technologies · Israel

Summary of the technology

Sp1-Protein Variants as Novel Scaffolds for the Formation of Functional Interfaces Between Electrodes, Neurons, Cells and their Surroundings
Project ID : 7-2011-2681

Yissum - Research Development Company of the Hebrew University

Description of the technology

Category

LifeSciences and BioTechnology

Keywords

Neural Network, SP1, Electrodes, Generating, Electronic Devices, Pore, Ohmic, Plasma Membrane

Current development stage

TRL3 Experimental proof of concept

Application

Improved electrical connections between neurons and electronic devices for human-device improved interface and for research

Highlights

The ring-like Stable Protein 1 (SP1) is a homo-dodecamer with an outer diameter of 11nm and an inner pore of 3 nm. SP1 was recently proposed as a new self-assembled molecular scaffold for Nano biotechnology and biomaterials applications. Various SP1 derivatives can serve as a scaffold to display various protein domains attributing a cooperative effect to the resultant protein, forming enzymatic nanotubes

Our Innovation

  • SP1 dissolves into the plasma membrane of living cells, leading to the generation of nano-pores and increasing of the membrane conductance.
  • Applying 1.8 nm gold nano-particles to the SP1 treats cells functionally plugs the inner pore, leading to the recovery of the membrane conductance.

Advantages

  • FlexibiliSP1 can be covalently linked to various surfaces (such as gold, silicon oxide etc.)
  • This allows cells and sensing pads to electrically couple off, leading to the assembly of neuroelectronic hybrid systems.

Technology

6His-SP1 links to gold surfaces of microelectrodes and parts into the plasma membrane. Technology shows that forms of SP1 could generate controlled Ohmic coupling between sensing pads and excitable cells.

Fig. 2. wtSP1 induces membrane depolarization and decreased input resistance.

(a) Control neuron - the relationships between the input resistance and transmembrane potential was established by measuring the voltage drop in response to a constant rectangular current pulse injected into the neuron, while shifting the transmembrane voltage to various values by DC current. The value to which the membrane potential was set is indicated on the left-hand side. (b) The relations between Rin and the transmembrane potential in four control neurons. Rin was calculated from the voltage drop generated by a 2 sec long, 0.3 nA hyperpolarizing square pulls current injection. To evaluate directly the effects of wtSP1 on the transmembrane potential and Rin, wtSP1 (2 M) was applied to the bathing solution while the membrane potential and input resistance were measured (arrow, c). Note that approximately 10 min. after SP1 application the membrane depolarized and the input resistance was transiently elevated. Insert in c- representative traces of the recorded voltage drop in response to a constant rectangular current injection pulse before and 15 minutes after wtSP1 application. (d) Variability in the rate of SP1-induced membrane depolarization (n=5). (e) The effects of wtSP1 on membrane potential are reversible upon washes (dashed line)in 4 out of 6 experiments.

Opportunity

In combination with the formation of high seal resistance between the cells and the sensing pads and the controlled and localized functionalism of sensing pads, generation of Ohmic coupling between the interior of neurons and sensing pads of electronic devices is possible and sustainable.

Project manager

Shani Bullock
VP, Business Development, Healthcare

Project researchers

Micha E Spira
HUJI, Faculty of Science
The Alexander Silberman Institute for Life Sciences

Oded Shoseyov
HUJI, Faculty of Agricultural, Food and Environmental Quality Sciences
Plant Sciences and Genetics

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Recombinant DNA
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Toxicology Market
  • In vitro Testing, Trials Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Gene Expression, Proteom Research Market
  • Bioinformatics Market
  • Enzymology/Protein Engineering/Fermentation
  • Genetic Engineering Market
  • Diagnostic
  • Therapeutic
  • Other Medical/Health Related
  • Anatomy, Pathology, Immunology, Physiology
  • Clinical Medicine
  • Life Science & Biotechnology
  • medical device

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.